Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.

Koszałka P, Pryszlak A, Gołuńska M, Kolasa J, Stasiłojć G, Składanowski AC, Bigda JJ.

Oncol Rep. 2014 Feb;31(2):819-27. doi: 10.3892/or.2013.2883. Epub 2013 Nov 29.

PMID:
24297662
2.

CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.

Koszałka P, Gołuńska M, Stanisławowski M, Urban A, Stasiłojć G, Majewski M, Wierzbicki P, Składanowski AC, Bigda J.

Int J Biochem Cell Biol. 2015 Dec;69:1-10. doi: 10.1016/j.biocel.2015.10.003. Epub 2015 Oct 13.

PMID:
26545615
3.

Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.

Koszałka P, Gołuńska M, Urban A, Stasiłojć G, Stanisławowski M, Majewski M, Składanowski AC, Bigda J.

PLoS One. 2016 Mar 10;11(3):e0151420. doi: 10.1371/journal.pone.0151420. eCollection 2016.

4.

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.

Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemelä J, Laurila JP, Elima K, Jalkanen S, Salmi M.

Eur J Immunol. 2011 May;41(5):1231-41. doi: 10.1002/eji.201041292.

5.

Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix.

Zhou P, Zhi X, Zhou T, Chen S, Li X, Wang L, Yin L, Shao Z, Ou Z.

Cancer Biol Ther. 2007 Mar;6(3):426-31. Epub 2007 Mar 29.

PMID:
17471030
6.

The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.

Bavaresco L, Bernardi A, Braganhol E, Cappellari AR, Rockenbach L, Farias PF, Wink MR, Delgado-Cañedo A, Battastini AM.

Mol Cell Biochem. 2008 Dec;319(1-2):61-8. doi: 10.1007/s11010-008-9877-3. Epub 2008 Jul 18.

PMID:
18636315
7.

Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.

Sadej R, Spychala J, Skladanowski AC.

Melanoma Res. 2006 Jun;16(3):213-22.

PMID:
16718268
8.

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ.

Cancer Res. 2011 Apr 15;71(8):2892-900. doi: 10.1158/0008-5472.CAN-10-4246. Epub 2011 Feb 3.

9.

Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.

Burghoff S, Gong X, Viethen C, Jacoby C, Flögel U, Bongardt S, Schorr A, Hippe A, Homey B, Schrader J.

BMC Cancer. 2014 Dec 2;14:898. doi: 10.1186/1471-2407-14-898.

10.

Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, Yin L, Shao Z, Ou Z, Zhou P.

J Cancer Res Clin Oncol. 2008 Mar;134(3):365-72. Epub 2007 Aug 2.

PMID:
17671792
11.

Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.

Ryzhov SV, Pickup MW, Chytil A, Gorska AE, Zhang Q, Owens P, Feoktistov I, Moses HL, Novitskiy SV.

J Immunol. 2014 Sep 15;193(6):3155-64. doi: 10.4049/jimmunol.1400578. Epub 2014 Aug 15.

12.

Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.

Forte G, Sorrentino R, Montinaro A, Luciano A, Adcock IM, Maiolino P, Arra C, Cicala C, Pinto A, Morello S.

J Immunol. 2012 Sep 1;189(5):2226-33. doi: 10.4049/jimmunol.1200744. Epub 2012 Jul 23.

13.

Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.

Hart ML, Henn M, Köhler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL, Eltzschig HK.

FASEB J. 2008 Aug;22(8):2784-97. doi: 10.1096/fj.07-103911. Epub 2008 Mar 19.

14.

The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.

Kim M, Ham A, Kim JY, Brown KM, D'Agati VD, Lee HT.

Kidney Int. 2013 Jul;84(1):90-103. doi: 10.1038/ki.2013.43. Epub 2013 Feb 20.

15.
16.

Anti-CD73 therapy impairs tumor angiogenesis.

Allard B, Turcotte M, Spring K, Pommey S, Royal I, Stagg J.

Int J Cancer. 2014 Mar 15;134(6):1466-73. doi: 10.1002/ijc.28456. Epub 2013 Sep 18.

17.

The roles of CD73 in cancer.

Gao ZW, Dong K, Zhang HZ.

Biomed Res Int. 2014;2014:460654. doi: 10.1155/2014/460654. Epub 2014 Jul 14. Review.

18.

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.

Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, Zhang B.

J Clin Invest. 2011 Jun;121(6):2371-82. doi: 10.1172/JCI45559. Epub 2011 May 2.

19.

The volatile anesthetic isoflurane increases endothelial adenosine generation via microparticle ecto-5'-nucleotidase (CD73) release.

Kim M, Ham A, Kim KY, Brown KM, Lee HT.

PLoS One. 2014 Jun 19;9(6):e99950. doi: 10.1371/journal.pone.0099950. eCollection 2014.

20.

Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines.

Bernardi A, Bavaresco L, Wink MR, Jacques-Silva MC, Delgado-Cañedo A, Lenz G, Battastini AM.

Eur J Pharmacol. 2007 Aug 13;569(1-2):8-15. Epub 2007 May 22.

PMID:
17568578

Supplemental Content

Support Center